Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001628280-24-000866

Chief Financial Officer sold 16,104 shares at an average $35.27 ($567,910)

  • Chief Financial Officer acquired 75,000 shares (grant or award)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Myszkowski Kenneth Allen · Chief Financial Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2024-01-04 Grant or award : show line 1 in the form 10b5-1 +75,000 456,704 D
2024-01-05 Sale : show line 2 in the form 10b5-1 −1,400 $34.04 $47,656 455,304 D
2024-01-05 Sale : show line 3 in the form 10b5-1 −5,800 $34.97 $202,826 449,504 D
2024-01-05 Sale : show line 4 in the form 10b5-1 −8,904 $35.65 $317,428 440,600 D
Open-market sales · 16,104 sh · avg $35.27 · $567,910
Loading xslF345X05/wk-form4_1704752198.xml…